Obesity among African American people in the United States: A review
- PMID: 36695059
- PMCID: PMC10107750
- DOI: 10.1002/oby.23640
Obesity among African American people in the United States: A review
Abstract
Obesity is a growing public health crisis in the United States and is associated with a substantial disease burden due to an increased risk for multiple complications, including cardiovascular and metabolic diseases. As highlighted in this review, obesity disproportionately affects the African American population, women in particular, regardless of socioeconomic status. Structural racism remains a major contributor to health disparities between African American people and the general population, and it limits access to healthy foods, safe spaces to exercise, adequate health insurance, and medication, all of which impact obesity prevalence and outcomes. Conscious and unconscious interpersonal racism also impacts obesity care and outcomes in African American people and may adversely affect interactions between health care practitioners and patients. To reduce health disparities, structural racism and racial bias must be addressed. Culturally relevant interventions for obesity management have been successfully implemented that have shown benefits in weight management and risk-factor reduction. Strategies to improve health care practitioner-patient engagement should also be implemented to improve health outcomes in African American people with obesity. When managing obesity in African American people, it is critical to take a holistic approach and to consider an individual's social and cultural context in order to implement a successful treatment strategy.
Obesity© 2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society.
Conflict of interest statement
Holly Lofton has served as a consultant for Allergan, Amgen, Bausch Health Americas, Becton Dickinson & Co, Eisai, Eli Lilly and Company, Endo Pharmaceuticals, Ethicon, Nalpropion, Novo Nordisk, Shire North American Group, and Takeda Pharmaceuticals North America. Jamy D. Ard has served as a consultant for Eli Lilly and Company, Nestle Healthcare Nutrition, and Novo Nordisk and has received research funding from Eli Lilly and Company and Epitomee Medical. Rameck R. Hunt has served as a speaker for Novo Nordisk. Michael G. Knight has served as a consultant for Novo Nordisk.
Figures



References
-
- Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389:1453‐1463. - PubMed
-
- Fryar CD, Carroll MD, Afful J. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960–1962 through 2017–2018. National Center for Health Statistics Health E‐Stats. Updated January 29, 2021. Accessed July 2, 2021. https://www.cdc.gov/nchs/data/hestat/obesity-adult-17-18/obesity-adult.htm
-
- Himmelstein MS, Puhl RM, Quinn DM. Intersectionality: an understudied framework for addressing weight stigma. Am J Prev Med. 2017;53:421‐431. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials